Neurokinin 3 receptor antagonism–the magic bullet for hot flushes?

Climacteric

Volumn 20, Issue 6, 2017, Pages 505-509

  Prague, J K ^a   Dhillo, W S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

hot flushes; Neurokinin 3 receptor; randomized controlled trial

Indexed keywords

NEUROKININ 3 RECEPTOR; NEUROKININ B; SEX HORMONE; TACHYKININ 3 RECEPTOR; TACHYKININ RECEPTOR; UNCLASSIFIED DRUG;

GENE LOCUS; GENETIC RISK; GENETIC VARIATION; GENITAL SYSTEM; HORMONE DEFICIENCY; HOT FLUSH; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MENOPAUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; REPRODUCTION; REVIEW; SIGNAL TRANSDUCTION; ANTAGONISTS AND INHIBITORS; FEMALE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

FEMALE; HOT FLASHES; HUMANS; MENOPAUSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, NEUROKININ-3;

EID: 85033242158     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697137.2017.1385598     Document Type: Review

References (45)

1. Stearns V, Ullmer L, Lopez JF, Smith Y, Isaacs C, Hayes D., Hot flushes. Lancet 2002;360:1851–61
2. Carpenter JS, Woods NF, Otte JL, et al. MsFLASH participants’ priorities for alleviating menopausal symptoms. Climacteric 2015;18:859–66
3. Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 2015;175:531–9
4. Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J., Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 2017;1:CD004143
5. National Institute for Health and Care Excellence. Menopause: diagnosis and management. NICE Guideline [NG23]. 2015. https://www.nice.org.uk/guidance/ng23
6. Drewe J, Bucher KA, Zahner C., A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients. Springerplus 2015;4:65
7. Ayers B, Smith M, Hellier J, Mann E, Hunter MS., Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial. Menopause 2012;19:749–59
8. Franco OH, Chowdhury R, Troup J, et al. Use of plant-based therapies and menopausal symptoms: a systematic review and meta-analysis. JAMA 2016;315:2554–63
9. Office for National Statistics. UK census. https://www.ons.gov.uk/census/2011census/2011censusdata (accessed Jan 7, 2017)
10. Freedman RR., Physiology of hot flashes. Am J Hum Biol 2001;13:453–64
11. Rance NE, Dacks PA, Mittelman-Smith MA, Romanovsky AA, Krajewski-Hall SJ., Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushes. Front Neuroendocrinol 2013;34:211–27
12. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H., Methodologic lessons learned from hot flash studies. J Clin Oncol 2001;19:4280–90
13. Bahr DE, Webster JG, Grady D, et al. Miniature ambulatory skin conductance monitor and algorithm for investigating hot flash events. Physiol Meas 2014;35:95–110
14. Sturdee DW, Hunter MS, Maki PM, et al. The menopausal hot flush: a review. Climacteric 2017;20:296–305
15. Casper RF, Yen SS, Wilkes MM., Menopausal flushes: a neuroendocrine link with pulsatile luteinizing hormone secretion. Science 1979;205:823–5
16. Boulant JA., Role of the preoptic-anterior hypothalamus in thermoregulation and fever. Clin Infect Dis 2000;31(Suppl 5):S157–S61
17. Nakamura K, Morrison SF., A thermosensory pathway mediating heat-defense responses. Proc Natl Acad Sci USA 2010;107:8848–53
18. Gallicchio L, Whiteman MK, Tomic D, Miller KP, Langenberg P, Flaws JA., Type of menopause, patterns of hormone therapy use, and hot flashes. Fertil Steril 2006;85:1432–40
19. Baker FC, Driver HS., Circadian rhythms, sleep, and the menstrual cycle. Sleep Med 2007;8:613–22
20. Charkoudian N, Johnson JM., Female reproductive hormones and thermoregulatory control of skin blood flow. Exerc Sport Sci Rev 2000;28:108–12
21. Navarro VM, Gottsch ML, Chavkin C, Okamura H, Clifton DK, Steiner RA., Regulation of gonadotropin-releasing hormone secretion by kisspeptin/dynorphin/neurokinin B Neurons in the arcuate nucleus of the mouse. J Neurosci 2009;29:11859–66
22. Folkers K, Lu YA, Rosell S., Synthesis and biological activities of neurokinin alpha and beta. Biochem Biophys Res Commun 1984;118:405–8
23. Navarro VM., Interactions between kisspeptins and neurokinin B. Adv Exp Med Biol 2013;784:325–47
24. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E., Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 2003;100:10972–6
25. Seminara SB, Messager S, Chatzidaki EE, et al. The GPR54 gene as a regulator of puberty. N Engl J Med 2003;349:1614–27
26. Topaloglu AK, Reimann F, Guclu M, et al. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for neurokinin B in the central control of reproduction. Nat Genet 2009;41:354–8
27. Rance NE, McMullen NT, Smialek JE, Price DL, Young 3WS., Postmenopausal hypertrophy of neurons expressing the estrogen receptor gene in the human hypothalamus. J Clin Endocrinol Metab 1990;71:79–85
28. Rance NE, Young WS., 3rd, Hypertrophy and increased gene expression of neurons containing neurokinin-B and substance-P messenger ribonucleic acids in the hypothalami of postmenopausal women. Endocrinology 1991;128:2239–47
29. Rometo AM, Krajewski SJ, Voytko ML, Rance NE., Hypertrophy and increased kisspeptin gene expression in the hypothalamic infundibular nucleus of postmenopausal women and ovariectomized monkeys. J Clin Endocrinol Metab 2007;92:2744–50
30. Cholanian M, Krajewski-Hall SJ, Levine RB, McMullen NT, Rance NE., Electrophysiology of arcuate neurokinin B neurons in female Tac2-EGFP transgenic mice. Endocrinology 2014;155:2555–65
31. Cholanian M, Krajewski-Hall SJ, McMullen NT, Rance NE., Chronic oestradiol reduces the dendritic spine density of KNDy (kisspeptin/neurokinin B/dynorphin) neurones in the arcuate nucleus of ovariectomised Tac2-enhanced green fluorescent protein transgenic mice. J Neuroendocrinol 2015;27:253–63
32. Magoun H, Harrison F, Brobeck J, Ranson S., Activation of heat loss mechanisms by local heating of the brain. J Neurophysiol 1938;1:101–14
33. Shughrue PJ, Lane MV, Merchenthaler I., In situ hybridization analysis of the distribution of neurokinin-3 mRNA in the rat central nervous system. J Comp Neurol 1996;372:395–414
34. Burke MC, Letts PA, Krajewski SJ, Rance NE., Coexpression of dynorphin and neurokinin B immunoreactivity in the rat hypothalamus: morphologic evidence of interrelated function within the arcuate nucleus. J Comp Neurol 2006;498:712–26
35. Krajewski SJ, Burke MC, Anderson MJ, McMullen NT, Rance NE., Forebrain projections of arcuate neurokinin B neurons demonstrated by anterograde tract-tracing and monosodium glutamate lesions in the rat. Neuroscience 2010;166:680–97
36. Dacks PA, Krajewski SJ, Rance NE., Activation of neurokinin 3 receptors in the median preoptic nucleus decreases core temperature in the rat. Endocrinology 2011;152:4894–905
37. Dacks PA, Krajewski SJ, Rance NE. Ambient temperature and 17β-estradiol modify Fos immunoreactivity in the median preoptic nucleus, a putative regulator of skin vasomotion. Endocrinology 2011;152:2750–9
38. Mittelman-Smith MA, Williams H, Krajewski-Hall SJ, McMullen NT, Rance NE., Role for kisspeptin/neurokinin B/dynorphin (KNDy) neurons in cutaneous vasodilatation and the estrogen modulation of body temperature. Proc Natl Acad Sci USA 2012;109:19846–51
39. Mittelman-Smith MA, Krajewski-Hall SJ, McMullen NT, Rance NE., Neurokinin 3 receptor-expressing neurons in the median preoptic nucleus modulate heat–dissipation effectors in the female rat. Endocrinology 2015;156:2552–62
40. Jayasena CN, Comninos AN, De Silva A, et al. Effects of neurokinin B Administration on reproductive hormone secretion in healthy men and women. J Clin Endocrinol Metab 2014;99:E19–27
41. Jayasena CN, Comninos AN, Stefanopoulou E, et al. Neurokinin B administration induces hot flushes in women. Sci Rep 2015;5:8466
42. Crandall CJ, Manson JE, Hohensee C, et al. Association of genetic variation in the tachykinin receptor 3 locus with hot flashes and night sweats in the women’s health initiative study. Menopause 2017;24:252–61
43. Prague JK, Roberts RE, Comninos AN, et al. Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 2017;389:1809–20
44. Fraser GL, Depypere H, Timmerman D, et al. Clinical evaluation of the NK3 receptor antagonist Fezolinetant (a.k.a. ESN364) for the treatment of menopausal hot flushes. Endocrine Rev 2017;38 (3 Suppl):OR16-5
45. Skorupskaite K, George JT, Veldhuis JD, Millar RP, Anderson RA., Neurokinin 3 receptor antagonism reveals roles for neurokinin B in the regulation of gonadotropin secretion and hot flashes in postmenopausal women. Neuroendocrinology 2017; Epub ahead of print